全文获取类型
收费全文 | 6296篇 |
免费 | 2822篇 |
国内免费 | 10篇 |
专业分类
林业 | 117篇 |
农学 | 505篇 |
1463篇 | |
综合类 | 50篇 |
农作物 | 141篇 |
水产渔业 | 2053篇 |
畜牧兽医 | 2992篇 |
园艺 | 3篇 |
植物保护 | 1804篇 |
出版年
2022年 | 1篇 |
2021年 | 118篇 |
2020年 | 477篇 |
2019年 | 913篇 |
2018年 | 800篇 |
2017年 | 848篇 |
2016年 | 657篇 |
2015年 | 623篇 |
2014年 | 565篇 |
2013年 | 832篇 |
2012年 | 954篇 |
2011年 | 556篇 |
2010年 | 500篇 |
2009年 | 228篇 |
2008年 | 251篇 |
2007年 | 124篇 |
2006年 | 105篇 |
2005年 | 106篇 |
2004年 | 99篇 |
2003年 | 88篇 |
2002年 | 91篇 |
2001年 | 78篇 |
2000年 | 92篇 |
1999年 | 6篇 |
1998年 | 1篇 |
1997年 | 1篇 |
1996年 | 2篇 |
1994年 | 6篇 |
1993年 | 3篇 |
1992年 | 1篇 |
1990年 | 1篇 |
1986年 | 1篇 |
排序方式: 共有9128条查询结果,搜索用时 15 毫秒
101.
102.
The 5‐lipoxygenase inhibitor tepoxalin induces oxidative damage and altered PTEN status prior to apoptosis in canine osteosarcoma cell lines
下载免费PDF全文
![点击此处可从《Veterinary and comparative oncology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
J. P. Loftus D. Cavatorta J. J. Bushey C. B. Levine C. S. Sevier J. J. Wakshlag 《Veterinary and comparative oncology》2016,14(2):e17-e30
The 5‐lipoxygenase (5‐LOX) inhibitor tepoxalin has been shown to slow canine osteosarcoma (OSA) tumour xenografts growth, yet the mechanisms are poorly elucidated. Further examination of tepoxalin in canine OSA cell lines shows that tepoxalin treated cells undergo apoptosis through caspase‐3 activation and annexin staining. Interestingly, apoptosis is superseded by an increase in reactive oxygen species (ROS), as measured by activation of dihydrorhodamine 123 and mitosox. This increase in ROS appears to be related to the 5‐LOX inhibitor regardless of cellular 5‐LOX status, and was not observed after treatment with the tepoxalin metabolite RWJ20142. Additionally, 5‐LOX inhibition by tepoxalin appears to increase phosphatase and tensin (PTEN) homolog activity by preventing its alkylation or oxidation. PTEN modification or inhibition allows phosphoinositide‐3 (PI3) kinase activity thereby heightening activation of protein kinase B (AKT) phosphorylation. Our data suggest that off target oxidation and LOX inhibition play roles in the apoptotic response. 相似文献
103.
104.
Lymphangiosarcoma (LAS) is an uncommon malignant neoplasia arising from lymphatic endothelium; little information exists regarding therapy. Single institutional retrospective review for canine LAS histopathology diagnoses over a 15‐year period yielded 12 dogs. Ten dogs were presented for a mass and/or swelling at cervical, trunk or limb regions. Prior to diagnosis, 10 dogs received empiric wound therapy. Cytology performed in 10 consisted of mild inflammation. Survival ranged from 60, 168 and 876 days for three dogs with palliation; 90 days with prednisone in one; 182 days with chemotherapy in one; 240, 267, 487, 630 and 941 days for five receiving surgery; and 574 days for one receiving surgery, radiation and chemotherapy. One dog is alive with recurrence at 243 days following surgery and carboplatin chemotherapy. Clinical improvement existed in LAS dogs receiving multimodal therapies. Early tissue biopsies are recommended for progressive oedematous lesions of unknown origin. 相似文献
105.
Thromboelastographic evidence of inhibition of fibrinolysis after ε‐aminocaproic acid administration in a dog with suspected acute traumatic coagulopathy
下载免费PDF全文
![点击此处可从《Journal of Veterinary Emergency and Critical Care》网站下载免费的PDF全文](/ch/ext_images/free.gif)
106.
Comparison of 4 point‐of‐care blood gas analyzers for arterial blood gas analysis in healthy dogs and dogs with cardiopulmonary disease
下载免费PDF全文
![点击此处可从《Journal of Veterinary Emergency and Critical Care》网站下载免费的PDF全文](/ch/ext_images/free.gif)
107.
108.
109.
110.
ASVCP guidelines: quality assurance for portable blood glucose meter (glucometer) use in veterinary medicine
下载免费PDF全文
![点击此处可从《Veterinary clinical pathology / American Society for Veterinary Clinical Pathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Karen L. Gerber Kathleen P. Freeman 《Veterinary clinical pathology / American Society for Veterinary Clinical Pathology》2016,45(1):10-27
Portable blood glucose meters (PBGM, glucometers) are a convenient, cost effective, and quick means to assess patient blood glucose concentration. The number of commercially available PBGM is constantly increasing, making it challenging to determine whether certain glucometers may have benefits over others for veterinary testing. The challenge in selection of an appropriate glucometer from a quality perspective is compounded by the variety of analytic methods used to quantify glucose concentrations and disparate statistical analysis in many published studies. These guidelines were developed as part of the ASVCP QALS committee response to establish recommendations to improve the quality of testing using point‐of‐care testing (POCT) handheld and benchtop devices in veterinary medicine. They are intended for clinical pathologists and laboratory professionals to provide them with background knowledge and specific recommendations for quality assurance (QA) and quality control (QC), and to serve as a resource to assist the provision of advice to veterinarians and technicians to improve the quality of results obtained when using PBGM. These guidelines are not intended to be all‐inclusive; rather they provide a minimum standard for management of PBGM in the veterinary setting. 相似文献